Dicot AB (XSAT:DICOT) Debt-to-Revenue : N/A (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Dicot AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.00 Mil. Dicot AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.00 Mil. Dicot AB's annualized Revenue for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Dicot AB Debt-to-Revenue Historical Data

The historical data trend for Dicot AB's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Debt-to-Revenue Chart

Dicot AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

N/A

Dicot AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Dicot AB's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot AB's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dicot AB's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot AB's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dicot AB's Debt-to-Revenue falls into.

Dicot AB Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Dicot AB's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	N/A
	=	N/A

Dicot AB's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

Dicot AB Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dicot AB's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

KN0:Germany

Address

Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37

Website

http://www.dicot.se

Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines